Executive Coaching for Women in Biotech & Pharma
In my work with women leaders in biotech and pharma, I witness the intense pressure of bridging science and business while carrying the weight of uncertainty and loss. Coaching helps you navigate this unique terrain, transforming the emotional volatility of drug development into resilient leadership that honors both your drive and your humanity.
- Between the Lab and the Boardroom: Leading Through Loss
- The Scientist’s Transition: From Data to Decisions
- Managing Emotional Volatility in Drug Development
- Building Resilience Amid Chronic Uncertainty
- Communicating Complex Results with Clarity and Compassion
- Leading Teams Through Setbacks and Failures
- Navigating Gendered Expectations in Executive Spaces
- Cultivating Sustainable Ambition and Well-Being
- Frequently Asked Questions
Between the Lab and the Boardroom: Leading Through Loss
The top-line data from the Phase III trial just came in. They missed the primary endpoint. Five years of relentless work, hundreds of millions of dollars, and the hopes of thousands of patients, all distilled into a single, unforgiving p-value. She sits still for a moment, the hum of the fluorescent lights overhead blending with the distant clatter of lab equipment. Her phone buzzes, a reminder: ten minutes until the boardroom.
She inhales deeply, feeling the familiar tightening in her chest. The grief she carries isn’t just personal; it’s collective. Tomorrow’s investors expect answers, and her team looks to her for steadiness. She locks that sorrow away in a mental box, no time to unravel now. With a steadying breath, she straightens her posture and steps forward to carry the weight that isn’t hers alone.
What I see consistently in my work with women in biotech and pharma is this exact tension: the need to navigate two worlds that rarely align. The meticulous, data-driven realm of science demands precision and patience. The boardroom, conversely, thrives on narrative, momentum, and confidence. The transition from scientist to executive requires more than new skills, it demands emotional agility to lead through the profound uncertainty and loss that drug development so often entails. Supporting this leadership is why coaching in this space must be as nuanced and resilient as the women it serves.
What Is The Scientist-Executive Divide?
In my work with clients stepping into leadership roles in biotech and pharma, I see firsthand how complex the transition can be from scientist to executive. Success as a scientist is grounded in data, rigor, and replicable results. You trust experiments, protocols, and evidence to guide your decisions. But executive leadership demands a different kind of fluency, one that blends narrative, influence, and strategic capital allocation. You’re no longer just managing experiments; you’re managing people, expectations, and sometimes even investors’ hopes.
What makes this shift uniquely challenging is the emotional intensity woven into the biotech and pharma industries. Drug development is a marathon, not a sprint, and often years of work hinge on a single clinical trial’s outcome. That uncertainty brings chronic stress and emotional volatility, even for the most resilient leaders. What I see consistently is that women in these roles face a dual pressure: mastering a new language of leadership while navigating the profound disappointments that come with the territory.
Coaching in this space isn’t about teaching business jargon. It’s about helping you bridge two worlds that rarely speak the same language. It’s about recognizing that your scientific rigor remains a strength even as you learn to lead with influence and vision. It’s about creating space for the very real grief and frustration that come with setbacks, while also building the resilience to keep pushing forward. This is a nuanced journey, one that demands empathy, precision, and a deep understanding of what’s at stake.
THE SCIENTIST-EXECUTIVE DIVIDE
The difficult transition from a role defined by data and scientific rigor to one defined by narrative, influence, and strategic capital allocation, especially within biotech and pharmaceutical leadership. This concept captures the challenge of integrating two distinct professional identities and the emotional volatility inherent in drug development. (Source: Linda Hill, PhD, Professor of Business Administration at Harvard Business School, who studies leadership transitions and organizational change.)
In plain terms: You’re moving from a world where facts and experiments drive your success to one where your ability to tell the story, inspire others, and make tough financial decisions matters just as much. It’s a big shift, and you’re learning how to lead in a whole new way.
The Neurobiology of Leading Between Data and Uncertainty
In my work with clients navigating biotech and pharma leadership, I often see how the body and brain respond to the unique pressures of this field. Leading in biotech means managing two worlds: the rigorous logic of science and the unpredictable rhythms of business. This duality triggers complex neurobiological responses that can overwhelm even the most driven and driven women. Understanding these responses helps us develop strategies that don’t just push through stress but transform it into sustainable leadership.
Stephen Porges, PhD, Distinguished University Scientist at Indiana University and originator of Polyvagal Theory, has shown how our nervous system reacts to stress by shifting between states of social engagement, fight-or-flight, and shutdown. For women executives in biotech, the chronic uncertainty of drug development, where years of work hinge on volatile clinical trials, can activate defensive states, making it harder to stay connected, creative, and confident. This isn’t a failure of willpower; it’s biology responding to a relentless environment. Recognizing these patterns allows us to build practices that help leaders regulate their nervous systems and stay present in high-stakes moments.
Bessel van der Kolk, MD, psychiatrist and trauma researcher at Boston University School of Medicine, author of The Body Keeps the Score, emphasizes how trauma and prolonged stress become embodied. The emotional volatility of leading teams through setbacks and clinical failures can create a “clinical failure burden” that weighs heavily on the body and mind. What I see consistently is that leaders who don’t have space to process these experiences carry invisible scars that impact decision-making, resilience, and relationships. Coaching creates a container where these burdens can be acknowledged and transformed, not ignored.
Another critical factor is the “scientist-executive divide,” a term coined to describe the challenging transition from roles defined by data and rigor to those defined by narrative, influence, and capital allocation. Christina Maslach, PhD, social psychologist at UC Berkeley who defined the three dimensions of burnout, notes that this transition often triggers identity stress and role confusion. In my clinical experience, women in biotech leadership feel this divide keenly. They’re trained to trust empirical proof but must now navigate ambiguity and persuasion, which can feel like stepping into unknown neurobiological territory. Coaching supports this transition by integrating cognitive flexibility and emotional agility to bridge these worlds.
THE SCIENTIST-EXECUTIVE DIVIDE
The difficult transition from a role where success is defined by data and rigor to a role where success is defined by narrative, influence, and capital allocation. This shift challenges cognitive and emotional frameworks, increasing risk of burnout and identity stress, Christina Maslach, PhD, social psychologist at UC Berkeley who defined the three dimensions of burnout.
In plain terms: You’re moving from a world where facts and experiments prove your worth to one where your influence and storytelling matter just as much. That shift can feel confusing and exhausting, but it’s a skill you can build.
What makes this neurobiological landscape unique for women leaders in biotech is the intersection of emotional volatility, chronic ambiguity, and the weight of responsibility. I often guide clients to develop nervous system regulation techniques alongside cognitive strategies, helping them endure uncertainty without losing their sense of agency or well-being. This isn’t about toughing it out, it’s about rewiring your brain and body to lead with clarity and resilience, even when the stakes feel impossibly high.
COMPLIMENTARY CONSULTATION
You don’t have to figure this out alone.
Schedule a complimentary 20-minute consultation to explore whether executive coaching with Annie is the right next step.
When Science Meets Stakes: The Emotional Terrain of Biotech Leadership
In my work with women leaders in biotech and pharma, I see a unique and often invisible challenge: managing the tension between the exacting logic of science and the urgent demands of business leadership. These women often come from rigorous scientific backgrounds, where data and evidence shape every decision. Suddenly, they’re expected to master the equally complex language of finance, investor relations, and organizational politics. This duality creates a persistent internal conflict, where the clarity of lab results meets the ambiguity of leadership choices.
The emotional volatility in drug development is another defining feature. Women executives face months or years invested in clinical trials that can be undone by a single failed Phase III study. Unlike other industries, this failure isn’t just a missed target; it’s the collapse of hope for patients, teams, and the leader herself. What I see consistently is the pressure to maintain a composed, confident exterior while privately wrestling with the profound disappointment and self-doubt that accompany these setbacks.
Leadership in biotech also means guiding teams through this emotional turbulence. Driven women in these roles often feel isolated, carrying the weight of team morale and investor confidence on their shoulders. They’re tasked with translating complex scientific setbacks into narratives that sustain belief and forward momentum. Coaching in this context involves helping leaders hold space for their own vulnerability while modeling resilience and vision for their teams.
Sloane, VP of Clinical Development, sits alone in her office at 7:15 pm, the hum of fluorescent lights blending with the distant clatter of the cleaning crew. The last email from the trial site blinks on her screen: the Phase III results are negative. She re-reads the data summary, heart sinking despite knowing every nuance inside out. Her calendar still shows tomorrow’s investor call, but all she can feel is the crushing gap between her public poise and private despair. As she leans back, her eyes close briefly, and a single tear escapes, unseen, unheard, a quiet moment of vulnerability before the relentless demands of leadership resume.
Bridging the Scientist-Executive Divide: Embracing a New Leadership Identity
In my work with clients who’ve transitioned from the lab bench to the boardroom, I see the Scientist-Executive Divide as one of the most challenging shifts. You’re moving from a world where success is measurable, objective, and rooted in data to a world where influence, narrative, and strategic capital allocation define your impact. This transition isn’t just about acquiring new skills; it requires a fundamental reshaping of your professional identity. The evidence that once made decisions clear can feel replaced by ambiguity and political nuance. That gap can trigger self-doubt and internal conflict, especially for driven women used to excelling through precision and measurable outcomes.
What I see consistently is that this divide often leads to a sense of isolation. You might feel caught between two cultures, the rigorous scientist who demands evidence and the executive who must persuade stakeholders, often relying on storytelling and emotional intelligence. The emotional labor involved in managing this dual identity can be exhausting, and without support, it can fuel imposter syndrome. The good news is you can develop a leadership style that honors both your scientific rigor and your executive presence. It’s about integrating these parts of yourself rather than feeling like you have to leave one behind.
This integration process also requires patience with ambiguity and resilience in the face of clinical failure. In biotech and pharma, years of meticulous work can be upended by a single trial result. As a leader, you carry the clinical failure burden, the psychological weight of guiding your team through these setbacks while maintaining vision and morale. Coaching helps you build the emotional stamina to hold space for this tension and keep steering forward, even when data and outcomes are uncertain.
“Leadership in science-driven industries demands not only intellectual agility but also a profound emotional resilience to navigate shifting roles and expectations.”
Herminia Ibarra, PhD, Professor of Organizational Behavior at London Business School, Harvard Business Review
THE SCIENTIST-EXECUTIVE DIVIDE
The difficult transition from a role where success is defined by data and rigor to a role where success is defined by narrative, influence, and capital allocation, as outlined by Herminia Ibarra, PhD, Professor of Organizational Behavior at London Business School.
You may have achieved incredible external success while feeling empty inside.
The intense pressure can create a trauma bond with your career.
Sometimes, childhood emotional neglect sets the stage for over-functioning in adulthood.
It is common to struggle with imposter syndrome despite your objective success.
Many women in this field experience institutional betrayal when systems fail to support them.
Your attachment patterns play a significant role in how you navigate professional relationships.
Through somatic therapy, we can help your body release stored tension.
We often use EMDR to process these deeply ingrained patterns.
In plain terms: You’re moving from a world where facts and experiments prove you’re right, to one where convincing others and making strategic calls shapes your success.
If you are looking for clinical therapy rather than executive coaching, please visit Therapy for Women in this Profession.
I see these same dynamics in my work with women in oncology.
I see these same dynamics in my work with women in emergency medicine.
I see these same dynamics in my work with women surgeons.
This mirrors what I see in my coaching work with female physicians.
This mirrors what I see in my coaching work with women in finance.
This mirrors what I see in my coaching work with women in emergency medicine.
Both/And: the brilliant scientist who understands the mechanism of action
In my work with women leaders in biotech and pharma, I often see a unique tension that’s hard to hold: You’re both the brilliant scientist who understands every nuance of a mechanism of action, and the executive drained by having to constantly translate that complex science into compelling stories for investors. These two roles demand very different skills, emotional bandwidth, and ways of thinking. The scientist thrives on data precision, rigorous testing, and incremental knowledge gains. The executive, on the other hand, must navigate ambiguity, manage expectations, and craft narratives that make science accessible and exciting to stakeholders who don’t speak the language of molecules and pathways.
What I see consistently is that this dual identity, this Both/And, creates an exhausting push and pull. You’re proud of your scientific rigor but frustrated when it feels like the business side only values the “story” and not the science. You want to lead your teams through the emotional volatility inherent in drug development, where years of work can be undone by a single clinical trial result. Holding these realities at once is draining, but it also opens a space for remarkable leadership growth when you learn to integrate both worlds rather than sacrificing one for the other.
Talia is Chief Scientific Officer at a biotech startup, navigating this exact tension. It’s late afternoon, and she’s just finished a meeting with the investor relations team. She listens as they rehearse the pitch, simplifying complex data into buzzwords and projections. Talia’s heart sinks. She knows the science behind their lead candidate inside and out, every cellular interaction, every potential side effect, but the story they’re selling feels like a fragile gloss over years of painstaking work. She feels caught between two worlds: the precise scientist who demands accuracy, and the executive who must sell a vision, sometimes glossing over inconvenient details. As she steps out of the conference room, she catches her reflection in the glass, tired, but resolute. In that moment, she recognizes she doesn’t have to choose between these roles. She can be both: the brilliant scientist and the strategic storyteller, learning to weave her deep expertise into a narrative that honors the complexity of the work and the demands of leadership.
The Systemic Lens: Navigating the Invisible Currents of Biotech Leadership
In my work with clients, what I see consistently is that the challenges women face in biotech and pharma leadership aren’t individual shortcomings but reflections of the industry’s unique systemic pressures. The funding model for biotech companies, largely dependent on venture capital and milestone-driven investments, creates a culture of chronic hypervigilance. Every clinical trial, every research milestone can either secure the next round of funding or trigger a cascade of setbacks. This environment demands relentless optimism but also an acute readiness for disappointment, and women leaders often find themselves managing not just business outcomes but the emotional fallout of scientific failure.
Women in biotech leadership are uniquely positioned at the intersection of two distinct worlds: the rigorous, data-driven domain of science and the high-stakes, narrative-driven realm of business and investment. This duality means they must translate complex scientific realities into compelling stories for investors, board members, and stakeholders. According to the 2023 Women in Biotech Report by Biotech Women’s Network, women hold only 18% of executive leadership roles in biotech firms, despite representing nearly 50% of the scientific workforce. This disparity underscores a structural hurdle: women are frequently promoted from hands-on scientific roles into executive positions without adequate support to navigate this transition’s emotional and strategic complexities.
The emotional volatility of drug development is profound. Years of rigorous research, meticulous data collection, and painstaking clinical trials can be unraveled overnight by a single unfavorable trial result. This unpredictability fosters a workplace culture where resilience isn’t just a personal trait but a survival mechanism. Women leaders often become the emotional anchors for their teams, tasked with sustaining morale amidst setbacks that are systemic, not personal failures. The biotech industry’s demand for constant innovation and rapid adaptation often overlooks the emotional labor involved in leading teams through these cycles of hope and disappointment.
Systemic gender dynamics compound these pressures. Research from the Journal of Pharmaceutical Innovation (2022) highlights that women executives report higher levels of burnout than their male counterparts, citing factors like exclusion from informal decision-making networks, skepticism toward their authority, and disproportionate expectations to manage interpersonal dynamics. In biotech, where the stakes involve human health and billions in investment, these dynamics intensify. Women aren’t just leading companies, they’re navigating a labyrinth of systemic expectations that require them to be scientists, storytellers, strategists, and emotional leaders simultaneously.
Executive coaching for women in biotech isn’t about fixing individual “gaps” but about equipping them to decode and respond to these systemic forces. It’s about helping women leaders embrace the complexity of their roles, build resilience in the face of chronic uncertainty, and lead teams through the inevitable failures embedded in scientific progress. When we shift the lens from “What’s wrong with me?” to “What’s happening in this system?” we open space for authentic growth, strategic navigation, and collective transformation.
Navigating the Path Forward: Trauma-Informed Coaching for Women Leaders in Biotech & Pharma
In my work with driven and driven women in biotech and pharma, trauma-informed executive coaching means meeting you where you are, both as a scientist and as a leader facing relentless uncertainty. This population carries a unique blend of pressures: the precision and skepticism ingrained by years in the lab, alongside the emotional complexity of guiding teams through the unpredictable, often devastating outcomes of clinical trials. Coaching here isn’t about quick fixes or surface-level strategies; it’s about creating a safe space to untangle the weight of chronic stress, professional identity shifts, and the emotional fallout of setbacks.
My approach integrates clinical understanding with executive coaching tailored specifically for this dual-world navigation. We focus on building resilience without glossing over the real trauma of failure, rejection, and volatility inherent in drug development cycles. You’ll find offerings that include one-on-one coaching, leadership development sessions, and structured support for managing the emotional labor that’s often invisible but profoundly felt. I help you translate your scientific rigor into executive presence while honoring the emotional complexity that comes with it. Together, we work on strengthening your capacity to lead authentically and effectively amid uncertainty.
What’s possible on the other side of this coaching journey is a leadership experience that feels more sustainable and aligned. You won’t just survive the emotional rollercoaster of biotech and pharma; you’ll develop tools to engage it with clarity and grounded confidence. This means cultivating a leadership style that embraces vulnerability as strength, navigating ambiguity without losing your sense of purpose, and inspiring teams through empathy grounded in deep understanding of the stakes involved. The transition from scientist to executive becomes less of an identity crisis and more of a powerful evolution.
This coaching path also opens doors to profound personal insight and growth. As you build skills to manage your emotional landscape, you often find renewed energy and passion for your work. The experience of feeling seen and supported in the unique challenges you face becomes a catalyst for lasting change, both professionally and personally. It’s about reclaiming your narrative and moving forward with intention, even when the path is uncertain.
Thank you for reading this far and for your courage in facing the complexities of leadership in biotech and pharma. If you’re feeling the weight of this journey and wondering what support might look like, know you’re not alone. I invite you to reach out and explore how trauma-informed executive coaching can be a source of strength and clarity as you step into your fullest leadership potential. Let’s navigate this path together.
READY TO BEGIN?
The next chapter starts with one conversation.
Schedule a complimentary 20-minute consultation to see if working with Annie is the right fit for where you are right now.
You don’t have to keep managing this alone. If you’re ready to explore what therapy or coaching could look like for you, I’d be honored to hear your story.
Q: What’s the difference between executive coaching and therapy?
A: Executive coaching typically focuses on enhancing leadership skills, decision-making, and career growth within a professional context. Therapy, on the other hand, addresses emotional healing, mental health, and deeper psychological patterns. In my work with clients, coaching helps navigate specific challenges in leadership roles, especially in biotech where the stakes and pressures are unique. Therapy might be more appropriate if you’re dealing with trauma or mental health conditions that impact your well-being beyond work. Both can complement each other but serve different purposes.
Q: What does ‘trauma-informed’ coaching actually mean?
A: Trauma-informed coaching means I work with an awareness that many driven women in biotech have experienced emotional trauma, whether from career setbacks, workplace dynamics, or the unpredictability of drug development. It’s about creating a safe, supportive space where your emotional responses are understood and respected, not dismissed. This approach helps you build resilience and leadership capacity without retraumatization. Christina Maslach, PhD, social psychologist at UC Berkeley who defined burnout, emphasizes the importance of addressing emotional exhaustion, which is a key part of trauma-informed care.
Q: I’m not sure if I need coaching or therapy, how do I know?
A: What I see consistently is that coaching is ideal when you’re ready to build specific leadership skills, manage workplace challenges, or step into a new executive role. Therapy is better suited if you’re struggling with ongoing emotional distress, trauma, or mental health issues that interfere with daily life. If you’re unsure, we can explore your goals together in an initial conversation. Sometimes, combining both delivers the best results, coaching for your career and therapy for your emotional well-being.
Q: My company offers coaching, how is working with Annie different?
A: Company-provided coaching often focuses on generic leadership skills or organizational goals without fully addressing the unique pressures women face in biotech and pharma. In my work, I prioritize trauma-informed, personalized coaching that understands the dual worlds of science and business you navigate daily. You’ll get a confidential, deeply empathetic space tailored to managing uncertainty, emotional volatility, and the transition from scientist to executive, all critical for sustainable leadership in this field.
Q: I’ve done leadership coaching before and it didn’t change anything, why would this be different?
A: What I hear often is that traditional coaching can feel surface-level, focusing on skills without addressing the emotional and identity shifts required in biotech leadership. My approach integrates clinical insight with coaching, helping you process the emotional toll of chronic uncertainty and high-stakes failure. This deeper work supports lasting change by addressing what’s beneath the surface, not just what’s visible. It’s designed for women who must lead through complexity, not just check boxes.
Q: How often are coaching sessions, and what if I need to reschedule?
A: Coaching sessions typically happen every 2-4 weeks, depending on your goals and schedule. I understand the demanding nature of biotech leadership, so I offer flexible scheduling to accommodate your availability. If you need to reschedule, just let me know at least 24 hours in advance, and we’ll find a new time. Consistency matters, but I also prioritize meeting you where you are rather than adding stress.
How does coaching account for the specific pace and uncertainty of the tech industry?
The tech industry creates a psychological environment unlike any other sector: constant disruption, compressed timelines, the expectation that you’ll simultaneously innovate and execute, and a culture that celebrates moving fast and breaking things, including, often, the people doing the moving. Coaching for women in tech leadership addresses the specific nervous system patterns this environment creates. We work on distinguishing between productive urgency and trauma-driven hypervigilance, between strategic risk-taking and the compulsive innovation that keeps you from ever feeling settled. Many of my tech clients discover that their most effective leadership emerges not from matching the industry’s frenetic pace but from developing an internal stability that allows them to move decisively without being reactive.
Related Reading
Maslach, Christina, and Michael P. Leiter. The Truth About Burnout: How Organizations Cause Personal Stress and What to Do About It. Jossey-Bass, 1997.
Sandberg, Sheryl. Lean In: Women, Work, and the Will to Lead. Knopf, 2013.
van der Kolk, Bessel A. The Body Keeps the Score: Brain, Mind, and Body in the Healing of Trauma. Viking, 2014.
Eagly, Alice H., and Linda L. Carli. Through the Labyrinth: The Truth About How Women Become Leaders. Harvard Business Review Press, 2007.
WAYS TO WORK WITH ANNIE
Individual Therapy
Trauma-informed therapy for driven women healing relational trauma. Licensed in 11 jurisdictions.
Executive Coaching
Trauma-informed coaching for driven women navigating leadership and burnout.
Fixing the Foundations
Annie’s signature course for relational trauma recovery. Work at your own pace.
Strong & Stable
The Sunday conversation you wished you’d had years earlier. 25,000+ subscribers.
Annie Wright, LMFT
LMFT · Relational Trauma Specialist · W.W. Norton Author
Helping driven women finally feel as good as their résumé looks.
Annie Wright is a licensed psychotherapist (LMFT #95719) and trauma-informed executive coach with over 15,000 clinical hours. She works with driven women, including Silicon Valley leaders, physicians, and entrepreneurs, in repairing the psychological foundations beneath their impressive lives. Annie is the founder and former CEO of Evergreen Counseling, a multimillion-dollar trauma-informed therapy center she built, scaled, and successfully exited. A regular contributor to Psychology Today, her expert commentary has appeared in Forbes, Business Insider, Inc., NBC, and The Information. She is currently writing her first book with W.W. Norton.
